+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss



L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss



Acta Oto-Laryngologica 132(4): 369-376



Combination therapy corticosteroids plus an oral antioxidant L-N-acetylcysteine (LNAC) was associated with improved hearing over corticosteroids alone, particularly at the 6-month follow-up and at high frequencies (i.e. 4000 Hz). This is the first report of a beneficial effect of LNAC in sudden idiopathic sensorineural hearing loss (SISNHL). To determine the association between antioxidant treatment and functional outcomes in SISNHL. This was a case-control study of adult patients with SISNHL, treated with oral prednisone plus intratympanic dexamethasone either alone or in combination with LNAC. The outcome measure was change in pure-tone thresholds at 500-4000 Hz. Hearing recovery was also recorded as the percentage of subjects with final pure-tone threshold average (PTA) within 50% of the difference between the initial value of the affected ear and the value of the unaffected ear. Comparisons were made between combination (corticosteroids plus LNAC) and single (no LNAC use) therapy groups. At 6 months, the mean PTA improvements were 26.1 dB and 15.1 dB for the combination and single therapy groups, respectively (p = 0.046). Higher gains at 4000 Hz were noted with LNAC use. The percentage of patients with at least 50% recovery was 63% and 35% for the combination and single therapy groups, respectively (p = 0.0319).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054054022

Download citation: RISBibTeXText

PMID: 22264083

DOI: 10.3109/00016489.2011.647359


Related references

Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome. Archives of Otolaryngology--Head and Neck Surgery 132(2): 193-195, 2006

A Retrospective Study of the Clinical Characteristics and Post-treatment Hearing Outcome in Idiopathic Sudden Sensorineural Hearing Loss. Audiology Research 7(1): 168, 2017

Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 268(4): 497-500, 2011

Association between Vestibular Function and Hearing Outcome in Idiopathic Sudden Sensorineural Hearing Loss. Korean Journal of Audiology 18(3): 131-136, 2015

Evaluation of cardiovascular risks and recovery of idiopathic sudden sensorineural hearing loss in hospitalised patients: comparison between complete and partial sudden sensorineural hearing loss. Journal of Laryngology and Otology 131(10): 919-924, 2017

The correlation between lipoprotein ratios and hearing outcome in idiopathic sudden sensorineural hearing loss patients. Clinical Otolaryngology 40(4): 355-362, 2016

Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 273(10): 3101-3107, 2017

Prognosticating hearing outcome in patients with idiopathic sudden sensorineural hearing loss by means of otoacoustic emissions and auditory brainstem response. Ear, Nose, and Throat Journal 96(12): E1-E5, 2018

Edaravone, a free radical scavenger, in the treatment of idiopathic sudden sensorineural hearing loss with profound hearing loss. Auris, Nasus, Larynx 37(1): 42-46, 2010

Treatment of Hearing Gain in Failed Idiopathic Sudden Sensorineural Hearing Loss. Otolaryngology - Head and Neck Surgery 147(2 Suppl.): P224-P224, 2012

Idiopathic sudden sensorineural hearing loss and acute low-tone sensorineural hearing loss: a comparison of the results of a nationwide epidemiological survey in Japan. Acta Oto-Laryngologica 137(Sup565): S38-S43, 2017

Prognostic Factors for the Hearing Outcome in Patients with Profound Idiopathic Sudden Sensorineural Hearing Loss (Isshl) Receiving the Triple Combined Therapy; 3 Grade 4 ;. Nippon Jibiinkoka Gakkai Kaiho 122(5): 757-763, 2019

Is the time from the onset to the treatment a prognostic indicator for hearing recovery in idiopathic sudden sensorineural hearing loss?. Kulak Burun Bogaz Ihtisas Dergisi 25(2): 70-76, 2016

The effect of initial treatment on hearing prognosis in idiopathic sudden sensorineural hearing loss: a nationwide survey in Japan. Acta Oto-Laryngologica 137(Sup565): S30-S33, 2017

Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome. Acta Oto-Laryngologica 130(3): 384-391, 2010